Invention Grant
- Patent Title: Inhibitors of hepatitis C virus replication
-
Application No.: US16829878Application Date: 2020-03-25
-
Publication No.: US11053243B2Publication Date: 2021-07-06
- Inventor: Craig A. Coburn , Steven W. Ludmerer , Kun Liu , Hao Wu , Richard Soil , Bin Zhong , Jian Zhu
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Jeffrey P. Bergman; Catherine D. Fitch
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D407/14 ; C07D487/04 ; C07D401/14 ; C07D403/14 ; C07D403/12 ; C07D413/14 ; C07D405/14 ; C07D405/12 ; C07D417/14 ; C07D409/14 ; A61K31/4985 ; A61K31/4439 ; A61K31/4184 ; A61K31/423 ; A61K31/4025 ; A61K31/519 ; A61K31/404 ; A61K31/506 ; A61K31/5377 ; A61K31/427 ; A61K31/4245 ; A61K31/475 ; A61K31/536 ; A61K31/4178 ; A61K31/517 ; A61K31/5386 ; A61K31/553 ; A61K31/437
Abstract:
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
Public/Granted literature
- US20200262836A1 INHIBITORS OF HEPATITIS C VIRUS REPLICATION Public/Granted day:2020-08-20
Information query
